Cargando…

Disparities in atrial fibrillation: a call for holistic care

Detalles Bibliográficos
Autores principales:	Kotalczyk, Agnieszka, Lip, Gregory Y.H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454813/ https://www.ncbi.nlm.nih.gov/pubmed/34557846 http://dx.doi.org/10.1016/j.lanepe.2021.100160

Ejemplares similares

Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation
por: Guo, Yutao, et al.
Publicado: (2022)

The 2020 ESC Guidelines on the Diagnosis and Management of Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2021)

One‐year Follow‐up Results of the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
por: Guo, Yutao, et al.
Publicado: (2021)

Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy: A Report From the ChiOTEAF Registry
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Outcomes in elderly Chinese patients with atrial fibrillation and coronary artery disease. A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
por: Guo, Yutao, et al.
Publicado: (2021)

Effects of the ABC pathway on clinical outcomes in a secondary prevention population of Chinese patients with atrial fibrillation: A report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry
por: Fawzy, Ameenathul M., et al.
Publicado: (2023)

4S‐AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients
por: Guo, Yutao, et al.
Publicado: (2022)

Stroke Prevention in Atrial Fibrillation: Where are We Now?
por: Ahmad, Yousif, et al.
Publicado: (2012)

Emerging Tools for Stroke Prevention in Atrial Fibrillation
por: Voukalis, Christos, et al.
Publicado: (2016)

Role of Monocytes in Heart Failure and Atrial Fibrillation
por: Shahid, Farhan, et al.
Publicado: (2018)

Atrial fibrillation, a contemporary sign of multimorbidity and irregular social inequity
por: Sagris, Dimitrios, et al.
Publicado: (2022)

Management of atrial fibrillation
por: Kakar, Puneet, et al.
Publicado: (2007)

The impact of frailty on the management of atrial fibrillation
por: Harrison, Stephanie L., et al.
Publicado: (2023)

Stroke Prevention in Atrial Fibrillation: Concepts and Controversies
por: Ahmad, Yousif, et al.
Publicado: (2012)

Stroke and Bleeding Risk in Atrial Fibrillation
por: Senoo, Keitaro, et al.
Publicado: (2014)

Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project
por: Xiong, Qinmei, et al.
Publicado: (2016)

Regional registries on the management of atrial fibrillation: Essential pieces in the global puzzle
por: Gumprecht, Jakub, et al.
Publicado: (2020)

How to Manage Atrial Fibrillation Secondary to Ibrutinib
por: Essa, Hani, et al.
Publicado: (2021)

Atrial Fibrillation and Oral Health
por: Hassan, Amaar, et al.
Publicado: (2021)

New use for an old drug: Metformin and atrial fibrillation
por: Vinciguerra, Manlio, et al.
Publicado: (2022)

The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2022)

Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry
por: Bayer, Valentina, et al.
Publicado: (2022)

Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients
por: Li, Yan-Guang, et al.
Publicado: (2018)

The Atrial Fibrillation Better Care pathway for managing atrial fibrillation: a review
por: Stevens, David, et al.
Publicado: (2021)

Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation
por: Rivera-Caravaca, José Miguel, et al.
Publicado: (2019)

Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?
por: Shantsila, Eduard, et al.
Publicado: (2016)

Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study
por: Potpara, Tatjana S, et al.
Publicado: (2013)

Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: A post-hoc analysis from the prospective GLORIA-AF Registry
por: Romiti, Giulio Francesco, et al.
Publicado: (2022)

Consumer-Led Screening for Atrial Fibrillation: A Report From the mAFA-II Trial Long-Term Extension Cohort
por: Guo, Yutao, et al.
Publicado: (2022)

Cardiovascular disease prevention: Risk factor modification at the heart of the matter
por: Fawzy, Ameenathul M., et al.
Publicado: (2021)

Antithrombotic therapy in chronic liver disease: to clot or not to clot
por: Calvert, Peter, et al.
Publicado: (2021)

Clinical review: Clinical management of atrial fibrillation – rate control versus rhythm control
por: Lim, Hoong Sern, et al.
Publicado: (2004)

Peripheral arterial disease: A high risk – but neglected – disease population
por: Tomson, Joseph, et al.
Publicado: (2005)

Atrial Fibrillation Increases the Risk of Early-Onset Dementia in the General Population: Data from a Population-Based Cohort
por: Kim, Dongmin, et al.
Publicado: (2020)

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
por: Liang, Hai-Feng, et al.
Publicado: (2019)

Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study
por: Højen, Anette Arbjerg, et al.
Publicado: (2022)

Artificial Intelligence in the Image-Guided Care of Atrial Fibrillation
por: Lyu, Yiheng, et al.
Publicado: (2023)

Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project
por: Deng, Hai, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pea1r5rbiv02ir2et71t7f1u29